早期的SGLT2i疗法促进了医院内ARNI的引入,改善了HFrEF患者的6个月缩功能
Andrea D'Amato1, Silvia Prosperi1, Federico Ferranti1
1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, 00161, Rome, Italy.
概括
在医院治疗心力衰竭与减少喷射分数 (HFrEF) 的时候,开始服用-葡萄糖共载体2抑制剂 (SGLT2i) 会增加引入血管新生素受体-尼普利辛抑制剂 (ARNI) 的可能性. 这种早期的SGLT2i策略也改善了左心室缩功能.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭需要及时进行疾病修饰疗法.
- 医院内启动HFrEF治疗的最佳时间正在调查中.
研究的目的:
- 评估是否早期在医院内启动-葡萄糖共运输体2抑制剂 (SGLT2i) 有助于引入血管激素受体-尼普利辛抑制剂 (ARNI).
- 为了评估这种策略是否能改善6个月后的左心室缩功能.
主要方法:
- 对连续的HFrEF患者进行前性,观察性,单中心研究.
- 有两组:第一组 (在医院开始SGLT2i) 和第二组 (在出院后开始SGLT2i).
- 在住院期间的ARNI引入和6个月后的心声学参数的比较.
主要成果:
- 早期住院SGLT2i预测出院前的ARNI开始 (OR:3.31,p<0.001).
- 在G1中,SGLT2i和ARNI联合治疗预测6个月后LVEF改善 (>10%) (OR:5.353,p<0.003).
结论:
- 在HFrEF患者的早期住院SGLT2i启动增加了住院ARNI引入的可能性.
- 这一策略与6个月后的左心室缩功能显著改善有关.
相关概念视频
Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Aortic Regurgitation III: Medical Management
396
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
396
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285


